391 related articles for article (PubMed ID: 17197190)
21. To give or not to give recombinant EPO to anemia endangered cancer patients.
Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
24. Risks and benefits of erythropoiesis-stimulating agents in cancer management.
Beutel G; Ganser A
Semin Hematol; 2007 Jul; 44(3):157-65. PubMed ID: 17631180
[TBL] [Abstract][Full Text] [Related]
25. [Erythropoietin and radiotherapy].
Le Fur E; Albarghach MN; Pradier O
Cancer Radiother; 2010 Jan; 14(1):81-6. PubMed ID: 20018547
[TBL] [Abstract][Full Text] [Related]
26. [Research advances in expression and functions of erythropoietin and erythropoietin receptor in cancers].
Li M; Lu Y; Chen XQ
Ai Zheng; 2008 Jun; 27(6):667-72. PubMed ID: 18570746
[TBL] [Abstract][Full Text] [Related]
27. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
Spaëth D
Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
[TBL] [Abstract][Full Text] [Related]
28. EPO's alter ego: erythropoietin has multiple actions.
Lappin TR; Maxwell AP; Johnston PG
Stem Cells; 2002; 20(6):485-92. PubMed ID: 12456956
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Anand A; Anand A; Anand N
Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
[No Abstract] [Full Text] [Related]
30. Anemia management in oncology and hematology.
Spivak JL; Gascón P; Ludwig H
Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
[TBL] [Abstract][Full Text] [Related]
31. Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
Larsson G; Janson ET
Eur J Cancer Care (Engl); 2008 Mar; 17(2):200-4. PubMed ID: 18302658
[TBL] [Abstract][Full Text] [Related]
32. Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO).
Burk R
Med Hypotheses; 2007; 69(6):1200-4. PubMed ID: 17493766
[TBL] [Abstract][Full Text] [Related]
33. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
[TBL] [Abstract][Full Text] [Related]
34. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
Henry DH
Semin Hematol; 1993 Oct; 30(4 Suppl 6):12-6. PubMed ID: 8153671
[TBL] [Abstract][Full Text] [Related]
37. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
38. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin-stimulating agents in oncology.
Savona MR; Silver SM
Cancer J; 2008; 14(2):75-84. PubMed ID: 18391611
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology.
Goodnough LT
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
